A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004)

Clinical trial NCT01500382 · TERMINATED

Trial details

NCT number: NCT01500382
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Overactive Bladder Overactive Urinary Bladder

Start date: 2012-02-27
Primary completion: 2013-01-02
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.